deltatrials
Completed PHASE1 NCT00132444

Study of UC-781 Vaginal Microbicide

Phase I Study of the Safety and Acceptability of UC-781 Topical Vaginal Microbicide in Heterosexual Women and Their Male Partners

Sponsor: CONRAD

Conditions HIV Infections
Interventions topical vaginal application of UC-781 gel
Updated 6 times since 2017 Last updated: Jan 6, 2010 Started: Oct 31, 2005 Primary completion: Dec 31, 2008 Completion: Dec 31, 2008

This PHASE1 trial investigates HIV Infections and is currently completed. CONRAD leads this study, which shows 6 recorded versions since 2005 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE1

  5. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE1

▶ Show 1 earlier version

  1. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE1

    First recorded

Oct 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • CONRAD
  • Centers for Disease Control and Prevention
  • Emory University
Data source: Centers for Disease Control and Prevention

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Decatur, United States